Michal Dubský
Michal Dubský is an expert in Endocrinology at Charles University (Czechia). As of October 2026, ScienceLeadR ranks Michal Dubský in the top 1% of experts in Czechia for Diabetes Mellitus. Michal Dubský has authored 71 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 269 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Infectiology - Cardiology - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2011 - 2026
Number : 71
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Male Sexual and Reproductive Health in Diabetes and Obesity Pharmacotherapy: A Source-Triangulated Counseling Map. PMID 42661473 — diabetes mellitus, glucagon-like peptide 1, erectile dysfunction, fertility, safety, parturition, pharmaceutical preparations, reproductive health, drug therapy, testosterone, obesity, counseling | Andrology | 2026 | 0 |
| Adaptation of quality control pipeline for Skeletal Muscle 31P MR Spectroscopy at 3T and 7T. PMID 42315455 — exercise, quality control, muscles, muscle weakness, recycling, muscle, skeletal | Z Med Phys | 2026 | 0 |
| Bone marrow cellular profile in patients with diabetes: association of statin therapy with CD34+ cells. PMID 42290843 — diabetes mellitus, cells, bone marrow, lymphocytes, stem cells, cell count, peripheral arterial disease, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors, ischemia, endocrine system diseases | Front Endocrinol (Lausanne) | 2026 | 0 |
| Tissue and Serum Concentrations of Time-Dependent Antibiotics in Infected Diabetic Foot Ulcers by Bolus or Continuous Administration: The Randomised DFIATIM Trial. PMID 42218112 — diabetes mellitus, serum, foot, foot ulcer, ulcer, diabetic foot, tissues, infections | Diabetes Metab Res Rev | 2026 | 0 |
| Artificial Intelligence in Diabetes Care. PMID 41913548 — diabetes mellitus, intelligence, language, insulin, algorithms, automation, learning, artificial intelligence, diabetes mellitus, type 1 | Diabetes Obes Metab | 2026 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
LeadR Networks
Main global connection map